These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34259944)

  • 21. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.
    Ferrer-Oliveras R; Llurba E; Cabero-Roura L; Alijotas-Reig J
    Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Lupus Anticoagulant With Long-Term Damage Accrual in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Jordan N; D'cruz DP
    Arthritis Care Res (Hoboken); 2016 May; 68(5):711-5. PubMed ID: 26415137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination.
    Ott O; Herrmann E; Schulz A; Lindhoff-Last E
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision medicine and the antiphospholipid syndrome: what is the future?
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811
    [No Abstract]   [Full Text] [Related]  

  • 28. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid Antibodies and Infection:
    Sciascia S; Radin M; Bazzan M; Montaruli B; Cosseddu D; Norbiato C; Bertero MT; Carignola R; Bacco B; Gallo Cassarino S; Roccatello D
    Front Immunol; 2021; 12():687534. PubMed ID: 34220842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Relationship Between Antiphospholipid Antibodies and COVID-19 Severity.
    Sadeghi A; Hasanlu M; Feyzi A; Mansori K; Ghodrati S; Parsamanesh N
    DNA Cell Biol; 2023 Jan; 42(1):65-71. PubMed ID: 36394439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
    Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
    Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort.
    Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    Front Immunol; 2021; 12():648881. PubMed ID: 34276646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiprothrombin antibody: why do we need more assays?
    Atsumi T; Koike T
    Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
    Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.